KBIO LABS Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 39

Employees

  • Stock Symbol
  • 038530

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $1.83
  • (As of Friday Closing)

KBIO LABS General Information

Description

Kbio Labs Inc, formerly known as Kbio Co Inc, is engaged in the biodistribution business, distributing life science-related equipment, reagents, and other materials, and a hardware, software, and IT services business within the ICT industry.

Contact Information

Website
www.kbiocompany.com
Formerly Known As
Core Cross, Gold Pacific, Maxus, Seoduinchip, Kbio, Kbio Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Suite 206
  • 834 Olympic-ro, Gangdong-gu, (Amsa-dong, Hangang City Life)
  • Seoul, 08389
  • South Korea
+82
Primary Industry
Distributors/Wholesale
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Corporate Office
  • Suite 206
  • 834 Olympic-ro, Gangdong-gu, (Amsa-dong, Hangang City Life)
  • Seoul, 08389
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KBIO LABS Stock Performance

As of 13-Nov-2026, KBIO LABS’s stock price is $1.83. Its current market cap is $8.45M with 4.62M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.83 $1.90 $1.83 - $9.53 $8.45M 4.62M 16.4K -$0.98

KBIO LABS Financials Summary

As of 30-Jun-2026, KBIO LABS has a trailing 12-month revenue of $63.4M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,866 17,049 26,532 10,608
Revenue 63,450 61,352 56,078 20,899
EBITDA (2,671) (3,890) (7,726) (9,258)
Net Income (10,255) (2,248) (4,977) (9,694)
Total Assets 48,199 82,529 79,532 110,907
Total Debt 193 407 513 2,473
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KBIO LABS Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KBIO LABS‘s full profile, request access.

Request a free trial

KBIO LABS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KBIO LABS Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KBIO LABS‘s full profile, request access.

Request a free trial

KBIO LABS Investments & Acquisitions (6)

KBIO LABS’s most recent deal was a Merger/Acquisition with Cure Bio (Distribution Business Division). The deal was made on 01-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cure Bio (Distribution Business Division) 01-Jan-2021 Merger/Acquisition Distributors/Wholesale
Danaeun 01-Oct-2019 Merger/Acquisition Distributors (Healthcare)
Hanjin Huef (1,406.97 Square Meter Portfolio of Land and Building in Seoul, South Korea) 31-Jan-2018 Corporate Asset Purchase Buildings and Property
FI-RA Photonics 31-Mar-2014 Merger/Acquisition Electrical Equipment
City Electronics 01-Jan-2004 Merger/Acquisition Electrical Equipment
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

KBIO LABS ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Distribution

Subindustry

Rank

Percentile

To view KBIO LABS’s complete esg history, request access »

KBIO LABS Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
City Electronics Seongnam, South Korea 2002
Danaeun Paju, South Korea

KBIO LABS FAQs

  • When was KBIO LABS founded?

    KBIO LABS was founded in 1997.

  • Where is KBIO LABS headquartered?

    KBIO LABS is headquartered in Seoul, South Korea.

  • What is the size of KBIO LABS?

    KBIO LABS has 39 total employees.

  • What industry is KBIO LABS in?

    KBIO LABS’s primary industry is Distributors/Wholesale.

  • Is KBIO LABS a private or public company?

    KBIO LABS is a Public company.

  • What is KBIO LABS’s stock symbol?

    The ticker symbol for KBIO LABS is 038530.

  • What is the current stock price of KBIO LABS?

    As of 13-Nov-2026 the stock price of KBIO LABS is $1.83.

  • What is the current market cap of KBIO LABS?

    The current market capitalization of KBIO LABS is $8.45M.

  • What is KBIO LABS’s current revenue?

    The trailing twelve month revenue for KBIO LABS is $63.4M.

  • What is KBIO LABS’s annual earnings per share (EPS)?

    KBIO LABS’s EPS for 12 months was -$0.98.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process